IDEAS home Printed from https://ideas.repec.org/a/aph/ajpbhl/10.2105-ajph.2015.302664_4.html
   My bibliography  Save this article

National and state treatment need and capacity for opioid agonist medication-assisted treatment

Author

Listed:
  • Jones, C.M.
  • Campopiano, M.
  • Baldwin, G.
  • McCance-Katz, E.

Abstract

Objectives. We estimated national and state trends in opioid agonist medication-assisted treatment (OA-MAT) need and capacity to identify gaps and inform policy decisions. Methods. We generated national and state rates of past-year opioid abuse or dependence, maximum potential buprenorphine treatment capacity, number of patients receiving methadone from opioid treatment programs (OTPs), and the percentage of OTPs operating at 80% capacity or more using Substance Abuse and Mental Health Services Administration data. Results. Nationally, in 2012, the rate of opioid abuse or dependence was 891.8 per 100 000 people aged 12 years or older compared with national rates of maximum potential buprenorphine treatment capacity and patients receiving methadone in OTPs of, respectively, 420.3 and 119.9. Among states and the District of Columbia, 96% had opioid abuse or dependence rates higher than their buprenorphine treatment capacity rates; 37% had a gap of at least 5 per 1000 people. Thirty-eight states (77.6%) reported at least 75% of their OTPs were operating at 80% capacity or more. Conclusions. Significant gaps between treatment need and capacity exist at the state and national levels. Strategies to increase the number of OA-MAT providers are needed. © 2015, American Public Health Association Inc. All rights reserved.

Suggested Citation

  • Jones, C.M. & Campopiano, M. & Baldwin, G. & McCance-Katz, E., 2015. "National and state treatment need and capacity for opioid agonist medication-assisted treatment," American Journal of Public Health, American Public Health Association, vol. 105(8), pages 55-63.
    • Handle: RePEc:aph:ajpbhl:10.2105/ajph.2015.302664_4
    DOI: 10.2105/AJPH.2015.302664
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.2105/AJPH.2015.302664
    Download Restriction: no
    File URL: https://libkey.io/10.2105/AJPH.2015.302664?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
    2. Meinhofer, Angélica & Witman, Allison E., 2018. "The role of health insurance on treatment for opioid use disorders: Evidence from the Affordable Care Act Medicaid expansion," Journal of Health Economics, Elsevier, vol. 60(C), pages 177-197.
    3. Johanna Catherine Maclean & Brendan Saloner, 2019. "The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 38(2), pages 366-393, March.
    4. Ellen Bouchery & Judith Dey, "undated". "Substance Use Disorder Workforce," Mathematica Policy Research Reports 47d4d14a7a32485eba249dfb3, Mathematica Policy Research.
    5. Caroline A King & Honora Englander & P Todd Korthuis & Joshua A Barocas & K John McConnell & Cynthia D Morris & Ryan Cook, 2021. "Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality," PLOS ONE, Public Library of Science, vol. 16(9), pages 1-14, September.
    6. Mary A. Burke, 2019. "Access to medication-assisted treatment for opioid use disorder: is Rhode Island different, and why?," Current Policy Perspectives 19-2, Federal Reserve Bank of Boston.
    7. Mary A. Burke & Riley Sullivan, 2020. "Medication-assisted Treatment for Opioid Use Disorder in Rhode Island: Who Gets Treatment, and Does Treatment Improve Health Outcomes?," New England Public Policy Center Research Report 20-3, Federal Reserve Bank of Boston.
    8. Aparna Soni & Lindsey Bullinger & Christina Andrews & Amanda Abraham & Kosali Simon, 2024. "The impact of state Medicaid eligibility and benefits policy on neonatal abstinence syndrome hospitalizations," Contemporary Economic Policy, Western Economic Association International, vol. 42(1), pages 25-40, January.
    9. Jayme E. Walters & Aubrey E. Jones & Aaron R. Brown & Dorothy Wallis, 2022. "Impacts of the COVID-19 Pandemic on a Rural Opioid Support Services Program," IJERPH, MDPI, vol. 19(18), pages 1-12, September.
    10. Emanuel Krebs & Jeong E. Min & Elizabeth Evans & Libo Li & Lei Liu & David Huang & Darren Urada & Thomas Kerr & Yih-Ing Hser & Bohdan Nosyk, 2017. "Estimating State Transitions for Opioid Use Disorders," Medical Decision Making, , vol. 37(5), pages 483-497, July.
    11. Mitchell, Penelope & Samsel, Steven & Curtin, Kevin M. & Price, Ashleigh & Turner, Daniel & Tramp, Ryan & Hudnall, Matthew & Parton, Jason & Lewis, Dwight, 2022. "Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior," Social Science & Medicine, Elsevier, vol. 302(C).
    12. Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aph:ajpbhl:10.2105/ajph.2015.302664_4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://www.apha.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.